BTIG analyst Yun Zhong reiterated a Buy rating on Anavex Life Sciences (AVXL - Research Report) yesterday and set a price target of $35.00. The company's shares closed yesterday at $11.67.Zhong covers the Healthcare sector, focusing on stocks such as Anavex Life Sciences, Mereo Biopharma Group Plc, and Passage Bio. According to TipRanks, Zhong has an average return of -11.8% and a 35.51% success rate on recommended stocks. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Anavex Life Sciences with a $35.20 average price target, implying a 201.63% upside from current levels.
https://www.tipranks.com/news/blurbs/anavex-life-sciences-avxl-receives-a-buy-from-btig-2?utm_source=advfn.com&utm_medium=referral
Anavex Life Sciences (NASDAQ:AVXL)
Historical Stock Chart
From Aug 2022 to Sep 2022 Click Here for more Anavex Life Sciences Charts.
Anavex Life Sciences (NASDAQ:AVXL)
Historical Stock Chart
From Sep 2021 to Sep 2022 Click Here for more Anavex Life Sciences Charts.